Table 3

Summary of results for prehabilitation versus no prehabilitation

OutcomesStudies, (n)Patients, (n)Heterogeneity test p valueI2 (%)WMD and 95% CI
Pain at 4 weeks or less42130.0855−6.1 (−10.6 to −1.6)*
Pain at 6–8 weeks54880.3116−1.4 (−5.5 to +2.6)
Pain at 12 weeks108060.0546−2.9 (−6.2 to +0.3)
Pain at 24 weeks32470.2233−2.5 (−5.6 to +0.6)
Pain at 1 year or more1109NANA−2.0 (−7.5 to +3.5)
Function at 4 weeks or less5257<0.00179−3.6 (−7.7 to +0.5)
Function at 6–8 weeks54880.2131−3.9 (−7.6 to −0.3)*
Function at 12 weeks12836<0.00169−4.0 (−7.5 to −0.5)*
Function at 24 weeks5345<0.00189−0.5 (−5.8 to +4.7)
Function at 1 year or more62960.990−0.6 (−2.6 to +145)
First days of climbing stairs (days)2990.440−1.4 (−1.9 to −0.8)*
First days of walking (days)2990.2429−0.2 (−0.4 to +0.002)
First days of use of toilet (days)2990.870−0.9 (−1.3 to −0.5)*
First days of use of chair (days)2990.500−1.2 (−1.7 to −0.8)*
SF-36 PCS at 6 weeks119NANA2.7 (−9.4 to +14.7)
SF-36 PCS at 12 weeks31490.1350−0.3 (−5.4 to +4.7)
SF-36 PCS at 24 weeks1109NANA0.0 (−3.4 to +3.4)
SF-36 PCS at 1 year1109NANA−3.0 (−6.4 to +0.4)
SF-36 MCS at 6 weeks117NANA−3.4 (−19.9 to +13.0)
SF-36 MCS at 12 weeks31490.720−0.4 (−3.7 to +2.9)
SF-36 MCS at 24 weeks1109NANA−1.0 (−4.9 to +2.9)
SF-36 MCS at 1 year1109NANA−2.0 (−5.1 to +1.1)
Length of stay (days)75070.680−0.3 (−0.8 to + 0.1)
Total cost (Canadian dollars)22420.990 +5 (−384 to +393)
  • Pain and function scores were converted to WOMAC (Western Ontario and McMaster Universities osteoarthritis index) 0–100 subscales, and high score indicates more pain or dysfunction.

  • *p<0.05.

  • MCS, mental component summary; NA, not applicable; PCS, physical component summary; WMD, weighted mean difference.